Page 386 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

4 LES NORMOUPÊMIANTS 347

MOORE W.M. "Terminal difluoro olefin analogues of squalene are time dépendent
inhibitors of squalene epoxydase" (1992) J Am Chem Soc, 114 (1), 360-361.
SATOH T. ef al. “Enzymatic properties of squalene epoxydase from Saccharomyces
cerevisiae" (1993) Biol Pharm Bull, 16 (4), 349-352.
CERUTTI M. ef al. "Synthesis and biological activity of 19-azasqualene 2,3-epoxydes
as inhibitors of 2,3-oxydo-squalene cyclase" (1993) Eur J Med Chem, 28 (9), 675-
682.
GROSA G. ef al. "Synthesis and biological activity of squalene dérivatives as irréver­
sible inhibitors of 2,3-oxydo-squalene cyclase" (1994) Eur J Med Chem, 29 (1), 17-
23.
Inhibiteurs de la 14a-déméthylase
AKHTAR M. et al. "Mechanistic studies on aromatase and related C-C bond cleaving
P-450 enzymes" (1993) J Steroid Biochem Molec Biol, 44 (4-6), 375-387.
MIETTINEN T.A. “Cholestérol metabolism during kétoconazole treatment in man"
(1988) J Lipid Res, 29, 43-51.
AUTRES NORMOLIPÉMIANTS
MCI-196 (1993) Drugs Future, 18 (1), 15-17.
BORMAN S. “Dow additive (HMPC) lowers cholestérol levels" (1993) Chemical and
Engineering News, 71,36-38.
DRESSMAN J.B. étal." High-molecular-weight hydroxypropylmethylcellulose, a cho­
lestérol lowering agent" (1993) Arch Int Med, 153 (11), 1345-1353.